











Javed, Ibrahim, Sun, Yunxiang, Adamcik, Jozef, Wang, Bo, Kakinen, Aleksandr, Pilkington, 
Emily H., Ding, Feng, Mezzenga, Raffaele, Davis, Thomas P. and Ke, Pu Chun. (2017) 
Cofibrillization of pathogenic and functional amyloid proteins with gold nanoparticles against 
amyloidogenesis. Biomacromolecules . 
 
Permanent WRAP URL: 
http://wrap.warwick.ac.uk/94814                         
 
Copyright and reuse: 
The Warwick Research Archive Portal (WRAP) makes this work by researchers of the 
University of Warwick available open access under the following conditions.  Copyright © 
and all moral rights to the version of the paper presented here belong to the individual 
author(s) and/or other copyright owners.  To the extent reasonable and practicable the 
material made available in WRAP has been checked for eligibility before being made 
available. 
 
Copies of full items can be used for personal research or study, educational, or not-for profit 
purposes without prior permission or charge.  Provided that the authors, title and full 
bibliographic details are credited, a hyperlink and/or URL is given for the original metadata 
page and the content is not changed in any way. 
 
Publisher’s statement: 
This document is the Accepted Manuscript version of a Published Work that appeared in 
final form in Biomacromolecules, copyright © American Chemical Society after peer review 
and technical editing by the publisher. 
 
To access the final edited and published work see 
http://dx.doi.org/10.1021/acs.biomac.7b01359  
 
A note on versions: 
The version presented here may differ from the published version or, version of record, if 
you wish to cite this item you are advised to consult the publisher’s version.  Please see the 
‘permanent WRAP url’ above for details on accessing the published version and note that 
access may require a subscription. 
 
For more information, please contact the WRAP Team at: wrap@warwick.ac.uk 
 
 1 
Co-fibrillization of pathogenic and functional amyloid 
proteins with gold nanoparticles against amyloidogenesis 
Ibrahim Javed,† Yunxiang Sun,§,# Jozef Adamcik,‡,# Bo Wang,§ Aleksandr Kakinen,† Emily H. 
Pilkington,† Feng Ding,*,§ Raffaele Mezzenga,‡ Thomas P. Davis,*,†,¶ and Pu Chun Ke*,† 
 
†ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Monash Institute of 
Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, VIC 3052, Australia 
§Department of Physics and Astronomy, Clemson University, Clemson, SC 29634, USA 
‡Food & Soft Materials, Department of Health Science & Technology, ETH Zurich, Schmelzbergstrasse 
9, LFO, E23, 8092, Zurich, Switzerland 
¶Department of Chemistry, University of Warwick, Gibbet Hill, Coventry, CV4 7AL, United Kingdom 
 
# YS and JA contributed equally to this work. 
 
Corresponding Author 








ABSTRACT. Biomimetic nanocomposites and scaffolds hold the key to a wide range of 
biomedical applications. Here we show, for the first time, a facile scheme of co-fibrillizing 
pathogenic and functional amyloid fibrils via gold nanoparticles (AuNPs) and their applications 
against amyloidogenesis. This scheme was realized by β-sheet stacking between human islet 
amyloid polypeptide (IAPP) and the β-lactoglobulin ‘corona’ of the AuNPs, as revealed by 
transmission electron microscopy, 3D atomic force microscopy, circular dichroism spectroscopy 
and molecular dynamics simulations. The biomimetic AuNPs eliminated IAPP toxicity, enabled 
X-ray destruction of IAPP amyloids, and allowed dark-field imaging of pathogenic amyloids and 
their immunogenic response by human T cells. In addition to providing a viable new 
nanotechnology against amyloidogenesis, this study has implications for understanding the in vivo 
cross-talk between amyloid proteins of different pathologies. 
 
 





The aggregation of proteins and peptides into cross-beta fibrils is a ubiquitous phenomenon 
associated with neurodegenerative disorders and type 2 diabetes, the amyloid diseases debilitating 
more than 5% of the global population.1, 2 Although much progress has been made in the past 
decades towards understanding the molecular and mesoscopic structures of protein fibrils as well 
as their fibrillization kinetics and toxicity, there is a crucial lack of strategies for probing the 
aggregation of amyloid proteins in situ, despite their relevance to elucidating the pathologies of 
amyloid diseases and to the development of effective theranostics.1, 3 
Nanoparticles (NPs) of metals, semiconductors and oxides possess distinct optical, electrical, 
magnetic and catalytic properties. The small size of NPs also enables their cellular translocation, 
biocirculation, and drug delivery. Accordingly, designing biomimetic nanocomposites and 
scaffolds holds great promise for bioremediation, diagnosis and disease intervention. Recently, 
Moore et al. examined the effects of gold NPs (AuNPs) on Alzheimer’s disease amyloid-β protein 
aggregation, and found that both the NP size and surface chemistry modulated the extent of protein 
aggregation while the NP charge influenced the aggregate morphology.4 Gladytz et al. succeeded 
in interfacing AuNPs and amyloid proteins,5 revealing that the amyloid aggregation of human islet 
amyloid polypeptide (IAPP) and prion protein SUP35 hinged on a balance between peptide-NP 
and peptide-peptide interactions. Hamley et al. demonstrated labelling of (Ala)10-(His)6 amyloid 
fibrils with AuNPs.6 Collectively, these studies demonstrated the feasibility of exploiting NP-
protein interactions against amyloidogenesis, an emerging field at the frontiers of materials, 
medicine, physical sciences, and bioengineering.  
IAPP is a 37-residue peptide involved in glycemic control, but its aggregation into amyloids and 
plaques is a hallmark of type 2 diabetes, a metabolic disease and a global epidemic. In contrast, β-
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lactoglobulin (bLg) is a natural whey protein which hydrolyzes into small peptide fragments upon 
heating and acid exposure (pH 2), and subsequently self-assembles into functional bLg amyloid 
fibrils.7, 8 Efficient in vitro iron delivery and wastewater purification have been recently 
demonstrated using bLg amyloids,9, 10 pointing to the untapped potential of this biomaterial. 
To develop biomimetic NPs against amyloidogenesis, we synthesized AuNPs using sonicated bLg 
amyloids as a β-sheet rich template (bLg AuNPs, ~8 nm in diameter; Scheme and Figure 1), which 
were then co-fibrillized with pathogenic IAPP. In addition, we synthesized AuNPs stabilized by 
heat-denatured bLg monomers (bLg-HDM AuNPs, ~6 nm in diameter; Scheme and Figure 1), 
which had a low β-sheet content. The use of AuNPs in this study was motivated by their 
biocompatibility as well as their potential for drug delivery, biosensing and photothermal 
therapy.11, 12 Following the synthesis, we examined the AuNPs within the context of IAPP 
fibrillization, toxicity, dark-field imaging, and destruction by localized heating of the AuNPs using 
X rays. Collectively, our results implicated bLg-AuNPs as a new nanomedicine against 
amyloidogenesis.  
EXPERIMENTAL METHODS 
Synthesis of gold nanoparticles (AuNPs). bLg amyloids were formed according to our reported 
method.13 Probe sonicated bLg amyloids (5 mL, 1 mg/mL) were introduced into the refluxing 
solution (10 mL) of HAuCl4 (0.5 mM) and 200 µL of NaBH4 (0.2 M) was added into the mixture, 
30 min later. Heating was stopped after ruby red-colored AuNPs were synthesized and kept on 
overnight stirring. bLg-HDM AuNPs were synthesized following the same method as with the bLg 
amyloid fragments. The bLg capped AuNPs were purified via centrifugal filtration. The 
concentrations of the AuNPs were derived according to the literature.14 
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Synthesis of AuNP-IAPP hybrids. Human islet amyloid polypeptide (IAPP; 37 residues, 2-7 
disulfide bridge, 3.9 kDa, >95% pure by HPLC) was obtained in lyophilized monomeric form from 
AnaSpec, and prepared in Milli-Q water at a stock concentration of 200 µM at room temperature 
with mixing immediately prior to use. AuNPs were co-fibrillated with IAPP by incubating 
different concentrations of the NPs with 25 μM of the peptide under ambient conditions for 24 h. 
bLg AuNPs (0.083 mM) were also incubated with 25 µM Amyloid β (1-42) obtained from 
AnaSpec, for 72 h in Mili-Q water before TEM visualization. 
Transmission electron microscopy and energy-dispersive X-ray spectroscopy. Transmission 
electron microscopy (TEM) and EDX spectral mapping were performed on an FEI Tecnai F20 
transmission electron microscope, operated at 200 kV with the samples adsorbed on a glow 
discharged (15 s) 400 mesh formvar-coated copper grid. Samples (25 μM of IAPP, 0.083 mM or 
0.11 mM of AuNPs) were then stained with 1 % uranyl acetate for visualization.  
Dynamic light scattering. Zeta potential and hydrodynamic size were acquired for the two types 
of AuNPs in aqueous solution (0.1 mM) at room temperature (Malvern Zetasizer). The stability of 
the AuNPs was evaluated by incubating the AuNPs (0.5 mM) with different concentrations of 
NaCl at 37 °C for 4 h and then analyzed for aggregation (Table S2). 
Circular dichroism spectroscopy. Circular dichroism (CD) spectra of the two types of AuNPs 
(0.25 mM) were obtained for the wavelength range of 190-240 nm with a 0.5 nm step size at room 
temperature. The data was converted from mean residue ellipticity (θ) to deg·cm2.dmol-1 and the 
protein secondary structure was estimated by DichroWeb, using Contin as reference program and 
reference set4.15 In addition, the CD spectra of bLg AuNPs associated IAPP amyloids before and 
after X-ray irradiation were acquired.  
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Thioflavin T assay. IAPP fibrillization in the presence of the two types of AuNPs was analyzed 
by a thioflavin T (ThT) assay. The assay was performed under ambient conditions with 100 µL of 
total reaction volume per well, consisting of 25 µM ThT dye, 25 μM of IAPP and 0.083 mM or 
0.11 mM of AuNPs in a 96 well-plate. The kinetic assay was carried out for 14 h with excitation 
and emission wavelengths of 440 nm and 485 nm at 25 °C. The kinetic parameters of lag time, 
fibrillation rate constant (k) and time to reach the half of fibrillization (t1/2) were calculated from 
the ThT data.16 The measurements were performed with 4 repeats for each sample condition and 
data was presented as mean ± standard deviation. 
Atomic force microscopy. Aliquots of 20 μL of AuNP-IAPP solution (IAPP concentration: 25 
µM, AuNPs: 0.083 mM, incubated 24 h) were deposited on freshly cleaved mica, left to adsorb 
for 2 min at room temperature, rinsed with MilliQ water, and gently dried with pressurized air. 
The samples were scanned on Nanoscope VIII Multimode Scanning Force Microscopes (Bruker) 
covered with an acoustic hood to minimize vibrational noise. The AFM was operated in tapping 
mode under ambient conditions using commercial silicon nitride cantilevers (Bruker). All AFM 
images were flattened to remove background curvature using the Nanoscope Analysis 1.5 software 
and no further image processing was carried out. 
Cytotoxicity assay. The IAPP control and the AuNPs with IAPP were incubated with human 
embryonic kidney 293 (HEK293) cells or pancreatic βTC6 cells (acquired from ATCC) in DMEM 
supplemented with 15% FBS and 1% penicillin/streptomycin at 37 ºC, 5% CO2. Endpoint 
cytotoxicity was determined by the percentage of propidium iodide (PI) positive cells after 24 h. 
The experiment was performed in triplicate. 
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Dark-field imaging. bLg AuNPs-IAPP hybrids were incubated for 30 min with human plasma 
proteins or CEM.NKR-CCR5 human T cells, obtained from the Department of Microbiology and 
Immunology, The Peter Doherty Institute for Infection and Immunity, The University of 
Melbourne. The samples were then mounted between a glass slide and a cover slip sandwiched 
with a double-sided tape and visualized by a dark-field microscope (CytoViva). 
X ray-induced destruction of AuNP-IAPP hybrids. IAPP as well as bLg AuNPs-IAPP hybrids 
were irradiated with X rays using a Bruker D8 advanced X-ray generator. The X rays (Cu source, 
Type Gaussian) were generated at 125 W energy (25 kV and 5 mA) and directed to the center of 
the sample holder with an 8×8 µm slit. Samples were exposed for 100 s with a dose of 300 µSv/h. 
The exposed samples were immediately prepared for TEM after the X-ray treatment.  
RESULTS & DISCUSSION 
Synthesis and characterizations of bLg AuNPs and bLg-HDM AuNPs 
Sonicated bLg fragments coated AuNPs via electrostatic interaction and surface adsorption, which 
prevented flocculation of the AuNPs against NaCl up to 2 M in concentration (Figure S1b, 
Supporting Information or SI). The AuNPs were monodisperse, but occasionally contained more 
than one NP per unit. The high stability of the bLg AuNPs (stable in water for at least 2 months of 
storage at 4 ºC) is essential for their biological applications without evoking destabilization 
through ligand exchange.11 The hydrolyzed bLg fragments were ~6 kDa.17 The 1-2 nm thick 
‘coronas’ of the bLg AuNPs (Figure 1a) were rich in β-sheets (>35%), resulting from bLg amyloids 
during the synthesis as corroborated by circular dichroism (CD) analysis (Figure 1e). In the CD 
spectra of bLg AuNPs, the negative peak absorbance around 218 nm indicates β-sheet 
conformation, whereas in the case of bLg-HDM AuNPs, the broad negative peak from 225 to 208 
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nm represents α-helices as the dominant conformation (Figure 1f).  The presence of α-helices in 
the AuNPs could be due to heat-induced conversion of β-sheets.18  
All-atom discrete molecular dynamics (DMD) simulations, a rapid and predictive molecular 
dynamics algorithm,19, 20 were employed to provide a molecular insight into the corona formation 
of bLg fragments and denatured full-length bLg on the surface of AuNPs.21 According to prior 
analysis of bLg amyloid formation and its binding with AuNPs,9, 22 the amyloid-forming segment 
117LACQCL122 from the native bLg sequence was chosen to model the AuNP-binding bLg 
amyloids, as described in the SI. The sequence is one of the most amyloidogenic regions in the 
native bLg sequence according to the zipperDB server, which estimates the propensity of a given 
6- or 7-residue sequence in forming the steric zipper cross-β conformation,18, 23 and contains two 
cysteines with strong binding affinity for AuNPs. We first evaluated the binding between a single 
sonicated bLg fibril (a two-layer β-sheet formed by ten peptides with the molecular mass of ~6 
kDa as identified experimentally,17 Figure S2) and a 4 nm spherical AuNP, where protein-AuNP 
interactions were adopted from the GolP force field (Methods, Figure S2b).24 The cross-β fibrils 
bound the AuNP in two modes, with either the fibril interface being parallel or perpendicular to 
the AuNP surface (Figures S2d, e). With more cross-β fibrils added to the system, formation of 
fibril ‘coronas’ was observed due to strong fibril-AuNP binding and inter-fibril interactions on the 
AuNP surface (Figure 1c). The interaction between a heat-denatured bLg monomer and an AuNP 
was also simulated at 350 K, where the unfolded protein was found to bind and spread over the 
AuNP surface with the native helices retained (Figure 1d, Figure S3), consistent with the CD 
measurement (Figures 1e, f). 
Fibrillization of pathogenic IAPP in the presence of bLg AuNPs and bLg-HDM AuNPs 
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Upon incubation with IAPP monomers in the aqueous phase, bLg AuNPs appeared within the 
contours of the IAPP fibrils indicating intercalation of the NPs with the fibrils (Figure 2a). In 
contrast, bLg-HDM AuNPs, consisting of AuNPs stabilized by heat-denatured bLg monomers, 
protruded out of the fibril contours resulting from surface adsorption of the NPs onto the IAPP 
fibrils upon their incubation (Figure 2c). Ligand exchange between the protein coating of bLg 
AuNPs and free IAPP monomers (prior to fibrillization) was unfavorable, due to strong binding 
between bLg fragments and AuNPs, as reflected by the high stability of the NPs against salt (Figure 
S1b) and time. The association between the bLg AuNPs and IAPP fibrils was confirmed by energy-
dispersive X-ray (EDX) mapping of the IAPP hybrids, which displayed a prominent elemental 
peak of Au (Figure S4). Three-dimensional atomic force microscopy (3D AFM) and AFM height 
scans (Figure 2e) further revealed intercalation (Figure 2b) or adsorption (Figure 2d) of AuNPs 
with respect to IAPP fibrils, consistent with the observations by transmission electron microscopy 
(TEM). It is necessary to mention that the IAPP fibrils alone were a mixture of different structural 
morphologies – many of the fibrils possessed the morphology of a twisted ribbon with a certain 
periodicity and handedness (Figures 2f, g), while the IAPP fibrils assembled in the presence of 
intercalated AuNPs did not display a distinct periodicity. This suggests a reduced cooperativity in 
the self-assembly of IAPP in the presence of the AuNPs.  
The effects of the AuNPs on IAPP fibrillization were examined by a thioflavin T (ThT) kinetic 
assay (Figure 2h). The parameters of lag time, aggregation rate constant (k) and time to reach half 
of the fibrillization (t1/2) were derived from the ThT data (Table S1).16 As bLg AuNPs mostly 
intercalated with IAPP during fibrillization, they notably prolonged the lag time due to the 
inclusion of AuNPs in IAPP self-assembly. The intercalation observed for IAPP and bLg AuNPs 
at ≤ 0.083 mM (See reference 13 for calculation of AuNP concentration) was absent at 0.11 mM, 
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as the NPs became adsorbed onto the fibril surfaces (Figure S5a). This can be understood as bLg 
AuNPs of high concentrations interacted more strongly among themselves, hence compromising 
NP-peptide interaction to favor peptide-peptide interaction.5 However, such interaction was not 
observed for α-helix rich bLg-HDM AuNPs at all concentrations, indicating the intercalation of 
bLg AuNPs with IAPP was not merely kinetic driven, but through β-sheet stacking. Accordingly, 
the kinetic parameters for the case of bLg-HDM AuNPs resembled that of the IAPP control (Table 
S1). Time-dependent TEM imaging further revealed the dynamic processes of IAPP interacting 
with the AuNPs (Figure S6), where IAPP-AuNP binding and co-fibrillization started to occur 
within the first hour. In addition, both AuNPs were found adsorbed onto preformed IAPP fibrils 
(Figures S7a, b), suggesting that co-fibrillization occurred prior to the saturation phase. Moreover, 
the association between bLg AuNPs and amyloidogenic proteins was found to be independent from 
peptide sequence or charge, as it occurred for both cationic IAPP and anionic amyloid-β (1-42) 
(Figures S5b&c), further pointing to the role of β-sheet stacking in rendering the hybrid 
architectures. 
To understand how bLg AuNPs were embedded within IAPP fibrils, docking simulations between 
model fibrils25 of IAPP and bLg fragment were performed. Briefly, the β-sheets in two fibrils were 
pre-aligned in parallel or anti-parallel by shifting each residue, followed by DMD simulations for 
structural relaxation and binding energy estimation. The binding mode with the highest binding 
affinity was selected (Figure 3). The two segments of 8ATQRLA13 and 26ILSSTN31 facing each 
other in the IAPP amyloid fibril were found to bind the double-layered LACQCL fibril in parallel 
by extensive backbone hydrogen bonding as well as side-chain polar and hydrophobic interactions 
(Figure 3c). These two IAPP segments partially overlapped with the two amyloidogenic segments 
of IAPP, 13ANFLVH18 and 22NFGAILS28, whose amyloid structures belonged to the class 2 and 
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class 7 steric zippers assuming a parallel, up-up, face-to-back and anti-parallel, up-up, face-to-
back packing of β sheets, respectively.23, 26 To confirm the fibrillization interactions of IAPP and 
bLg amyloids, we performed a ThT assay of IAPP in the presence of bLg amyloid seeds that were 
obtained by ultra-sonication of mature bLg amyloids (Figure S8). The enhanced ThT fluorescence 
and saturation plateau indicated the stimulatory effect of bLg amyloid seeds on IAPP fibrillization. 
Based on these observations and DMD simulations, we propose that IAPP fibrillization could be 
initiated by the existing bLg amyloid fragments on the AuNP surface, where the bLg fibrils had 
one of the fibril-growth interfaces bound to the 4-nm AuNP and the other one solvent-exposed and 
ready for co-fibrillization (Figure 3e).   
Applications of co-fibrillization against amyloidogenesis  
The two types of the AuNPs and the AuNP-IAPP hybrids were shown to be highly biocompatible 
with insulin-producing pancreatic βTC6 cells (Figure 2i) and human embryonic kidney (HEK293) 
cells (data not shown) and, most importantly, fully eliminated IAPP toxicity likely through 
sequestration of toxic IAPP oligomers and protofibrils with bLg. The AuNP-IAPP hybrids, with 
the coating of human plasma proteins (Figure 4a) to mimic the scenario of IAPP in circulation,27 
were clearly visible on dark-field microscopy via the surface plasmon resonance (SPR) of the 
AuNPs (CytoViva, Figure 4b). IAPP is synthesized and secreted by pancreatic islets for glycemic 
control, and has been found in the brain, heart and kidneys,28, 29 in addition to their presence in 
circulation.30 In the present study, phagocytosis of the hybrids by CEM.NKR-CCR5 human T cells 
was observed with dark-field microscopy (Figures 4c, d), circumventing the need of antibody 
labelling for immunogenic clearance of amyloid species in circulation.31 Furthermore, X-ray 
irradiation of IAPP hybridized with bLg AuNPs induced potent destruction of the amyloid 
structures through localized heating of AuNPs (Figures 4e, f). Such effect was not observed for 
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IAPP amyloids in the absence of AuNPs (Figure S9). It has been shown in the literature that X-ray 
irradiation of AuNPs resulted in localized hyperthermia (41~46 ºC), which was exploited for 
targeted photo-thermal therapy of cancer without harming normal tissue.32, 33 As the generated heat 
was highly confined to the bLg AuNPs embroidered inside IAPP fibrils, this scheme is not 
expected to induce significant damage to a cellular environment. The destructed IAPP fibrils were 
in the form of small aggregates. The β-sheet contents of IAPP-bLg AuNP hybrids were markedly 
reduced as a result of X-ray irradiation, from 34% to 5%, while the unordered contents were 
increased from 39% to 69% (Figures 4g, h), indicating that the destructed IAPP aggregates 
contained minimal toxic and β-sheet rich IAPP oligomers.34  
bLg AuNPs prolonged the lag time to accommodate their intercalation within the IAPP fibrils. 
Such intercalation may be understood from the surfactant-like nature of amyloidogenic peptides, 
as the β-sheets of IAPP protofibrils/fibrils sought to minimize their exposure to the aqueous 
environment (and hence free energy) by interfacing the bLg β-sheets on the NP surfaces.13 For 
bLg-HDM AuNPs, the lack of β-sheets (Figure 1e) coupled with their high zeta potential (Table 
S2) encouraged NP adsorption onto the IAPP fibrils. The short lag time (Figure 2h, Table S1) 
associated with bLg-HDM AuNPs may be attributed to heat-induced bLg denaturation and 
increased hydrophobicity, and hence increased affinity of bLg-HDM AuNPs for an IAPP ‘halo’ to 
facilitate fast fibrillization.5  
CONCLUSION  
Taken together, this study offers biomimetic AuNPs of coupling functional and pathogenic 
amyloids for toxicity elimination, X ray-induced destruction and dark-field imaging of 
phagocytosis of amyloid proteins, three new strategies for the detection and mitigation of 
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amyloidogenesis associated with a number of human diseases.31, 35 The novel synthesis schemes 
may be extended to the construction of other types of amyloid-metal biomimetics for biosensing. 
Furthermore, the molecular mechanism of β-sheet stacking between two amyloid species may have 
implications for understanding the in vivo cross-talk between proteins of different pathogenic 
origins that has so far eluded a biophysical underpinning.36  
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Scheme. Synthesis of AuNPs stabilized by sonicated bLg amyloids (bLg AuNPs) and heat-
denatured bLg monomers (bLg-HDM AuNPs).  
 
Figures and Captions  
 
Figure 1. Transmission electron microscopy (a, b) and discrete molecular simulations (c, d) show 
bLg AuNPs and bLg-HDM AuNPs. Circular dichroism spectroscopy indicates high β-sheet 
content in bLg AuNPs but not in bLg-HDM AuNPs (e, f). Scale bars in a, b: 10 nm. bLg amyloids 
of LACQCL (blue) coated on AuNPs (yellow spheres, 4 nm in diameter) (c). Full-length bLg 
molecules bound to an AuNP in the denatured state (d). Alpha-helices: purple, beta-sheets: orange, 




Figure 2. Transmission electron microscopy (a, c) and atomic force microscopy (b, d) show bLg 
AuNPs and bLg-HDM AuNPs incubated with IAPP after 24 h of co-fibrillization. The AFM height 
scans of the IAPP fibrils (e) correspond to panels b, d (white dashed lines). The height variations 
of the blue trace indicate adsorption of bLg-HDM AuNPs, while the relatively flat contour of the 
black trace suggests intercalation of bLg AuNPs with IAPP fibrils, in agreement with the TEM 
image in panel a. While transmission electron microscopy showed the electron densities of IAPP 
fibrils incubated with the AuNPs (dark spots, a, c), 3D atomic force microscopy revealed 
topologies of the IAPP fibrils in the presence of the AuNPs (b, d). The IAPP fibrils appeared 
intercalated with bLg AuNPs (a) while surface-adsorbed with bLg-HDM AuNPs (c). The IAPP 
control is shown in (f, g). The effects of the AuNPs on IAPP fibrillization were evaluated by a 
thioflavin T kinetic assay (h), where the IAPP control (25 μM) displayed standard sigmoidal 
kinetics while the AuNPs (0.083 mM, unless specified otherwise) affected the kinetics as also 
summarized in Table S1. The toxicity induced by IAPP (fixed at 25 µM) in pancreatic βTC6 cells 




Figure 3. Docking analysis between LACQCL and IAPP fibrils. The binding energy, ΔG, between 
the double-layered LACQCL and u-shaped IAPP fibrils, was plotted as a function of the number 
of shifted residues in parallel (a) and anti-parallel (b) alignments, respectively. The equilibrated 
snapshot structures with the corresponding lowest binding energies in parallel and anti-parallel are 
shown in (c, d). In both cases, similar regions in the IAPP bound to the LACQCL fibril, with the 
parallel alignment showing a slightly stronger binding affinity. A schematic of a bLg AuNP (4 nm) 










Figure 4. Transmission electron microscopy and dark-field microscopy of bLg AuNP-IAPP 
hybrids coated with human plasma proteins (a, b: 24 h incubation; inset in a: plasma proteins 
without IAPP). Dark-field microscopy of human T cells (c) and human T cells phagocytosing a 
bLg AuNP-IAPP hybrid (d); inset in d: a T cell in the presence of IAPP fibrils. Scale bar: 4 μm. 
Yellow arrows: AuNPs. Red arrows: human plasma proteins. Destruction of IAPP amyloids via 
localized X-ray heating of bLg AuNPs before (e) and after (f) X-ray irradiation. CD spectra and 
corresponding secondary structures of IAPP control and IAPP hybridized with bLg AuNPs before 
and after X-ray irradiation (g, h).  
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